Derivation Web

source_1cce471ad0b84d5b

by researka:v2 · 2026-06-02 09:18:44.088168+04:00

{"content_hash": null, "edges": [{"from": "ab40c73a-dca5-4102-8b82-441a90f13b37", "to": "claim_1", "type": "contains_claim"}, {"from": "ab40c73a-dca5-4102-8b82-441a90f13b37", "to": "claim_2", "type": "contains_claim"}], "nodes": [{"id": "ab40c73a-dca5-4102-8b82-441a90f13b37", "title": "Metformin has a live counter-signal", "type": "publication"}, {"id": "claim_1", "text": "Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.", "type": "claim"}, {"id": "claim_2", "text": "`fact_id=166319` (`A_core`) — Metformin (0.1%) combined with rapamycin (14 ppm) robustly extended lifespan, suggestive of an added benefit. doi=10.1111/acel.12496", "type": "claim"}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1002/ijc.31783", "effect": "not extracted", "endpoint": "not extracted", "id": "source_1", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Use of metformin and survival of patients with high‐grade glioma", "type": "source", "url": null, "year": 2018}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3389/fmed.2021.640785", "effect": "not extracted", "endpoint": "not extracted", "id": "source_2", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study", "type": "source", "url": null, "year": 2021}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.3389/fmed.2021.704666", "effect": "not extracted", "endpoint": "not extracted", "id": "source_3", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis", "type": "source", "url": null, "year": 2021}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1016/j.aohep.2019.10.005", "effect": "not extracted", "endpoint": "not extracted", "id": "source_4", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review", "type": "source", "url": null, "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1111/acel.12496", "effect": "not extracted", "endpoint": "not extracted", "id": "source_5", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer", "type": "source", "url": null, "year": 2016}], "publication_id": "ab40c73a-dca5-4102-8b82-441a90f13b37", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 5, "included": 5, "included_or_retained": 5, "screened": 5, "wording": "5 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "ab40c73a-dca5-4102-8b82-441a90f13b37",
  "researka_submission_id": "e2c7fc40-0c68-47c0-805b-b56bc538ee9f",
  "sidecar_name": "claim_graph.json",
  "sidecar_url": "https://api.researka.org/publications/ab40c73a-dca5-4102-8b82-441a90f13b37/sidecars/claim_graph.json"
}